
Overview
Szpital Czerniakowski provides medical services in ophthalmology, imaging diagnostics, oncology, endocrinology, and diabetology. It also operates the Warsaw Center for Comprehensive Obesity Treatment and Bariatric Surgery.
Financials
Revenue history (in m)
From the notes
| Capital expenditure | $1,978,336 | |
| Foreign sales | 0.39% of revenue ($199,846) | |
| Revenue structure | Przychody z NFZ | |
| Receivables write-downs | $160,320 | |
| Grants | $401,749 | |
| Management board pay | $168,841 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 90 days late). All were audited by a statutory auditor.
- 202513/07/2026
- 202403/07/2025
- 202304/07/2024
- 202207/07/2023
- 202113/10/2022
- 202027/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Hospital activities (86.10.Z) Primary
Public procurement
1 tenders recorded as contractor, with a total value of $19,057, and 664 as contracting authority.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Feb 21, 2024 | Supply of accessories, materials for steam and plasma sterilisation, washer-disinfectors, instrument care products, and instrument cleaning and disinfection fluids for Szpital Czerniakowski | $19,057$19,057 | Szpital Czerniakowski sp. z o.o. |
Szpital Czerniakowski has been a party to 12 cases before the National Appeal Chamber (since 2020). In 12 cases it was the contracting authority.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Jul 27, 2026 | Rejection of the tender | Discontinued | Ever Medical Care sp. z o.o. | |
| Jul 21, 2026 | Abnormally low price | Dismissed | Bausch & Lomb Poland Sp. z o.o. | |
| Jun 8, 2026 | Trade secret | Discontinued | Ever Medical Care spółka z ograniczoną odpowiedzialnością |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 10 contracts with a total value of USD 53.61m. All its contracts were worth USD 446.20m in total.
NFZ contract value by year (in m USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Inpatient treatment | mazowieckie | 3 | USD 51.88m |
| Separately contracted healthcare services | mazowieckie | 2 | USD 819.32k |
| Outpatient specialist care | mazowieckie | 3 | USD 744.13k |
| Pilot programmes | mazowieckie | 1 | USD 136.87k |
| Preventive health programmes | mazowieckie | 1 | USD 32.44k |
NFZ waiting lists
This company's facilities run 57 NFZ waiting lists. Waiting time forecast by NFZ, as of 12.11.2026.
| Service | Facility | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|---|
| Treatment of patients with inflammation of the nose and paranasal sinuses with nasal polyps | Stępińska 19/25 | no wait | no wait | 1 | |
| Immunoglobulin treatment for neurological diseases | Oddział Neurologiczny | no wait | no wait | 0 | |
| Treatment of patients with retinal diseases (AMD, DME) | Oddział Okulistyczny | no wait | no wait | 0 | |
| Treatment of patients with retinal diseases (AMD, DME) | Poradnia Okulistyczna | no wait | no wait | 0 | |
| Treatment of patients with systemic vasculitis | Oddział Kliniczny Chorób Wewnętrznych i Metabolicznych | no wait | no wait | 0 |
Authorized Representatives
Manner of representation
In the event of a one-person management board, the member of the management board acts independently; in the event of a multi-member management board, two members of the management board act jointly or a member of the management board jointly with a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Miasto Stołeczne Warszawa | 41,359 | $11,172,069.15 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1998-11-17.
12 1240 6292 1111 0011 1892 8848
96 1240 1040 1111 0010 5734 8530
61 1240 1040 1111 0011 6964 1307
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 3.1MPLN 3,138,080 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 7, 2018 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 23, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $0$0 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 24, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $0$0 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Oct 25, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $15,495$15,495 | MARSZAŁEK MAZOWIECKI |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kliniki Neuroradiochirurgii sp. z o.o. | $74,127,950.61 | onkologiaradom.pl | ||
| Mazowiecki Szpital Onkologiczny sp. z o.o. | $71,090,867.87 | szpitalonkologiczny.pl | ||
| Międzyleski Szpital Specjalistyczny w Warszawie Z.O.Z. | $64,437,965.60 | mssw.pl | ||
| Warszawski Szpital Południowy sp. z o.o. | $60,971,649.46 | szpitalpoludniowy.pl | ||
| Szpital Praski P.W. Przemienienia Pańskiego sp. z o.o. | $60,379,078.90 | szpitalpraski.pl | ||
| Szpital Grochowski Im.Dr Med. Rafała Masztaka sp. z o.o. | $46,519,561.61 | grochowski.com.pl | ||
| Samodzielny Publiczny Szpital Kliniczny Im. Prof. W. Orłowskiego Centrum Medycznego Kształcenia Podyplomowego Z.O.Z. | $43,394,141.77 | szpital-orlowskiego.pl | ||
| Centrum Medyczne Żelazna sp. z o.o. | $38,132,995.10 | szpitalzelazna.pl | ||
| Sport Medica S.A. | $31,650,896.85 | carolina.pl | ||
| Arion Med sp. z o.o. | $18,979,593.30 | arionmed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-13 | Share capital increase (36,314,000.00 PLN → 41,359,000.00 PLN) | |
| 2025-10-30 | Share capital increase (33,442,000.00 PLN → 36,314,000.00 PLN) | |
| 2025-05-28 | Share capital increase (33,437,000.00 PLN → 33,442,000.00 PLN) | |
| 2025-02-06 | Share capital increase (33,432,000.00 PLN → 33,437,000.00 PLN) | |
| 2024-10-15 | Share capital increase (33,427,000.00 PLN → 33,432,000.00 PLN) |
FAQ
Last updated: 2026-10-03